https://www.thebodypro.com/category/fda-approved-hiv-medications

FDA-Approved HIV Medications

The Latest

Promo Image

Lack of Interaction Between Stavudine Extended-Release Formulation and Tenofovir Disoproxil Fumarate

Lack of Interaction Between Stavudine Extended-Release Formulation (d4T XR) and Tenofovir Disoproxil Fumarate (TDF) (Poster 534) Authored by S. Kaul, K. Bassi, B. Damle, R. Smith, J. Gale, E. O'Mara, U. Chaudhari, K. Ryan View the original ...

Promo Image

Pharmacokinetic Parameters of Atazanavir/Ritonavir When Combined to Tenofovir in HIV Infected Patients With Multiple Treatment Failures: A Substudy of Puzzle2-ANRS 107 Trial

Pharmacokinetic (PK) Parameters of Atazanavir (ATV)/Ritonavir (RTV) When Combined to Tenofovir (TDF) in HIV Infected Patients With Multiple Treatment Failures: A Substudy of Puzzle2-ANRS 107 Trial (Poster 537) Authored by A.M. Taburet, C. Piket...

Promo Image
News

GW433908 in ART-Naive Subjects: Absence of Resistance at 48 Weeks With Boosted Regimen and APV-Like Resistance Profile With Unboosted Regimen

GW433908 in ART-Naive Subjects: Absence of Resistance at 48 Weeks With Boosted Regimen and APV-Like Resistance Profile With Unboosted Regimen (Poster 598) Authored by S. Macmanus, P. Yates, S. White, N. Richards, W. Snowden View the origina...

Promo Image

New Questions About an Old Combination -- ddI + d4T

For the last several years, the combination of ddI (didanosine, Videx) and d4T (stavudine, Zerit) as a backbone of three-drug therapy has been popular both in treatment and in research. Together, the two nucleoside analog reverse transcriptase inhibi...

Promo Image

Entry Inhibitors: The Bouncers at the Door

T-20 T-1249 SCH-C PRO 542

There is good news on the horizon for people whose HIV is resistant to many currently approved antiretrovirals -- the development of a new class of anti-HIV drugs called entry inhibitors. Entry inhibitors have shown...

Promo Image
People Who Use Drugs

Methadone and HIV Medications: Drug Interactions

Who Needs to Care?

Injection drug use is a risk behavior that may result in acquired immunodeficiency syndrome (AIDS). Treatment for substance abuse may be an important part of AIDS prevention and treatment. Methadone is a medication used as a subst...

Promo Image

A Population Based-Analysis of Amprenavir Trough Concentrations Assessed in the Course of Therapeutic Drug Monitoring

A Population Based-Analysis of Amprenavir Trough Concentrations Authored by Kurowski M., Sternfeld T., and Sawyer A.W. Poster P187

The subject of therapeutic drug monitoring (TDM) has assumed increased importance in HIV patient management,...

Promo Image

Immune Reconstitution Is Similar in Antiretroviral-Naive Subjects Following 1 Year of Therapy With a Triple NRTI-Based or Protease Inhibitor-Containing ARV Regimen

Immune Reconstitution Is Similar in Antiretroviral (ARV)-Naive Subjects Following 1 Year of Therapy With a Triple NRTI-Based or Protease Inhibitor (PI)-Containing ARV Regimen Authored by Landay A., Spritzler J., Kessler H., Mildvan D., Pu M., F...

Promo Image
Lipodystrophy/Body Fat

Evaluation of Coronary Artery Calcification by Electron Beam Computed Tomography in HIV-Infected Men Receiving Prolonged Protease Inhibitor Therapy

Evaluation of Coronary Artery Calcification by Electron Beam Computed Tomography (EBCT) in HIV-Infected Men Receiving Prolonged Protease Inhibitor (PI) Therapy (Oral 25) Authored by David M. Parenti, Madeline M. Rice, Afsoon Roberts, Angelike L...

Promo Image

Study Examines Mortality Factors in HIV Patients on Protease Inhibitors

Despite a dramatic decline in mortality among human immunodeficiency virus (HIV)-infected adults in industrialized countries since the advent of highly active antiretroviral therapy (HAART), mortality remains higher among HIV-infected adults than in ...